Clinical Trials Logo

Internal Hemorrhoid clinical trials

View clinical trials related to Internal Hemorrhoid.

Filter by:
  • None
  • Page 1

NCT ID: NCT06250140 Not yet recruiting - Internal Hemorrhoid Clinical Trials

Recurrence Rate of Minimally Invasive Endoscopic Treatment of Internal Hemorrhoids

Start date: February 1, 2024
Phase:
Study type: Observational

2.1 Main objective: To observe the short-term and long-term recurrence rates of various endoscopic minimally invasive treatment methods for internal hemorrhoids and different time points of endoscopic minimally invasive treatment for internal hemorrhoids in patients with grade I-III internal hemorrhoids 2.2 Secondary objective: To observe the safety and efficacy of endoscopic minimally invasive treatment of internal hemorrhoids

NCT ID: NCT06106269 Recruiting - Internal Hemorrhoid Clinical Trials

Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids

HEMBO-1
Start date: June 7, 2024
Phase:
Study type: Observational

This study will assess how effective and safe rectal artery embolization works to treat symptomatic bleeding predominant internal hemorrhoids.

NCT ID: NCT06031740 Not yet recruiting - Liver Cirrhosis Clinical Trials

A Comparison of Flexible Endoscopic Polidocanol Liquid and Foam Sclerotherapy in Cirrhotic Patients With Bleeding From Internal Hemorrhoids

Start date: September 7, 2023
Phase: N/A
Study type: Interventional

Haemorrhoids are the most common proctologic disease, affecting up to 36% of people in the developed world. Sclerotherapy is defined as the injection of sclerosing agents at the apex of the internal hemorrhoidal complex, above the dentate line, leading to scarring, fibrosis, and fixation of the hemorrhoids. Sclerotherapy as a treatment of internal hemorrhoids has been used for a long time by surgeons, using proctoscopic exposure. Even though flexible instruments can be expected to have better manoeuvrability and target site exposure. There is no consensus amongst the major guidelines as to which grade of haemorrhoid that sclerotherapy should be used, whether it is equivalent or inferior to rubber bad ligation (RBL), whether sclerotherapy should be used at all for the treatment of IH, what is the effect of PHT on hemorrhoid prevalence and propensity to bleed, differentiation of internal hemorrhoids from rectal varices, data on EBL or EST in cirrhotics with hemorrhoids, safety of endotherapy with underlying coagulopathy and concerns for infectious complications.

NCT ID: NCT04169152 Recruiting - Rectal Prolapse Clinical Trials

CAES for Internal Hemorrhoids and Rectal Prolapse

Start date: December 30, 2019
Phase:
Study type: Observational

Cap-assisted endoscopic sclerotherapy (CAES) is a new interventional therapy for internal hemorrhoids and rectal prolapse under colonoscopy. However, the long-term efficacy and safety of CAES in the treatment of internal hemorrhoids and rectal prolapse are still not clear due to the lack of large sample studies. Therefore, a nationwide multi-center, large sample, prospective and cohort study was designed to evaluate the efficacy and safety of CAES in the treatment of internal hemorrhoids and rectal prolapse, to provide reliable evidence for popularization of this minimally invasive technology.

NCT ID: NCT03917056 Recruiting - Rectal Prolapse Clinical Trials

Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse

Start date: June 24, 2019
Phase: N/A
Study type: Interventional

This clinical trial aims to evaluate the efficacy and safety of long needle and short needle in the treatment of internal hemorrhoids and rectal prolapse through CAES (Cap-assisted endoscopic sclerotherapy).